WO2002053713A3 - Cloning of a human sulfotransferase - Google Patents

Cloning of a human sulfotransferase Download PDF

Info

Publication number
WO2002053713A3
WO2002053713A3 PCT/EP2001/015233 EP0115233W WO02053713A3 WO 2002053713 A3 WO2002053713 A3 WO 2002053713A3 EP 0115233 W EP0115233 W EP 0115233W WO 02053713 A3 WO02053713 A3 WO 02053713A3
Authority
WO
WIPO (PCT)
Prior art keywords
cloning
sulfotransferase
human sulfotransferase
human
activity
Prior art date
Application number
PCT/EP2001/015233
Other languages
French (fr)
Other versions
WO2002053713A2 (en
Inventor
Rainer H Koehler
Original Assignee
Bayer Ag
Rainer H Koehler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Rainer H Koehler filed Critical Bayer Ag
Priority to AU2002234600A priority Critical patent/AU2002234600A1/en
Publication of WO2002053713A2 publication Critical patent/WO2002053713A2/en
Publication of WO2002053713A3 publication Critical patent/WO2002053713A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91194—Transferases (2.) transferring sulfur containing groups (2.8)

Abstract

The present application discloses polynucleotide sequences coding for a novel human sulfotransferase. It also relates to methods for identifying modulators of the activity of said sulfotransferase.
PCT/EP2001/015233 2001-01-02 2001-12-21 Cloning of a human sulfotransferase WO2002053713A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002234600A AU2002234600A1 (en) 2001-01-02 2001-12-21 Cloning of a human sulfotransferase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25881201P 2001-01-02 2001-01-02
US60/258,812 2001-01-02

Publications (2)

Publication Number Publication Date
WO2002053713A2 WO2002053713A2 (en) 2002-07-11
WO2002053713A3 true WO2002053713A3 (en) 2002-11-14

Family

ID=22982230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015233 WO2002053713A2 (en) 2001-01-02 2001-12-21 Cloning of a human sulfotransferase

Country Status (2)

Country Link
AU (1) AU2002234600A1 (en)
WO (1) WO2002053713A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021148388A1 (en) 2020-01-20 2021-07-29 Universität Leipzig Method for the detection of hormonally active compounds, kit and their use
DE102020101223A1 (en) 2020-01-20 2021-07-22 Technische Universität Dresden Method for the detection of hormonally active compounds, kit and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072977A2 (en) * 2000-03-27 2001-10-04 Pe Corporation (Ny) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072977A2 (en) * 2000-03-27 2001-10-04 Pe Corporation (Ny) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] Database accession no. AAE12209 *
DATABASE EMBL [online] Database accession no. AF055584 *
DATABASE EMBL [online] Database accession no. L22339 *
NAGATA ET AL: "isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 268, no. 33, L22339, 25 November 1993 (1993-11-25), pages 24720 - 24725, XP002122424, ISSN: 0021-9258 *
SAKAKIBARA YOICHI ET AL: "Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 273, no. 51, AF055584, 18 December 1998 (1998-12-18), pages 33929 - 33935, XP002181293, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2002053713A2 (en) 2002-07-11
AU2002234600A1 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
WO2003070182A3 (en) Sodium channel blockers
WO2003070184A3 (en) Sodium channel blockers
WO2003023005A3 (en) Antisense modulation of pka regulatory subunit rii alpha expression
AU2002357859A1 (en) Elastic strand coating process
WO2003014307A3 (en) Antisense modulation of apolipoprotein(a) expression
ZA200408111B (en) Treatment of gastroparesis.
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
PL1668001T3 (en) Substituted heteroaryl benzofuran acids
MXPA03008777A (en) The use of enantiomeric pure escitalopram.
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1262556A3 (en) Antimicrobial peptides and method for identifying and using such peptides
AU2003250983A1 (en) The use of nucleotide sequences as carrier of information
ZA200301390B (en) Method of enhancing skin lightening.
WO2002095053A3 (en) Antisense modulation of src-c expression
WO2003052062A3 (en) Antisense modulation of cd36l1 expression
WO2002053713A3 (en) Cloning of a human sulfotransferase
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
MXPA03010498A (en) Process for the preparation of imipenem.
WO2002057408A3 (en) Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
WO2003027229A3 (en) Antisense modulation of rip2 expression
WO2002068457A3 (en) Antiangiogenic peptides derived from endostatin
WO2003031584A3 (en) Axon repair
WO2002083727A3 (en) Nucleic acid sequences of hyperplasies and tumors of the thyroid
WO1999053091A3 (en) Dna coding for gdnf, parts of said dna and gdnf variants
WO2004028447A3 (en) Novel compositions and methods for the treatment of psoriasis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP